Clinical Trials

NCT00621764 | COMPLETED | PHASE2

300 participants

Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2008-03-31

Completion:

2009-12-31

Conditions

• Japanese Encephalitis
• Hepatitis A

Interventions

• BIOLOGICAL

Results Available

NCT00599196 | COMPLETED | PHASE3

381 participants

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2002-08-31

Completion:

2008-12-31

Conditions

• Early Stage Parkinson's Disease

Interventions

• DRUG

Results Available

NCT00594464 | COMPLETED | PHASE4

14 participants

A Trial of Neupro® (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2007-09-30

Completion:

2008-05-31

Conditions

• Parkinson's Disease

Interventions

• DRUG

Results Available

NCT00594386 | COMPLETED | PHASE3

258 participants

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2002-08-31

Completion:

2008-12-31

Conditions

• Parkinson's Disease

Interventions

• DRUG

Results Available

NCT00594165 | COMPLETED | PHASE3

217 participants

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease.

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2002-06-30

Completion:

2008-11-30

Conditions

• Early-Stage Parkinson's Disease

Interventions

• DRUG

Results Available

NCT00593606 | COMPLETED | PHASE3

124 participants

Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2007-07-31

Completion:

2007-12-31

Conditions

• Parkinson's Disease

Interventions

• DRUG

Results Available

NCT00544609 | COMPLETED | PHASE1

10 participants

Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2007-12-31

Completion:

2010-08-31

Conditions

• Bladder Cancer

Interventions

• DRUG
• PROCEDURE

No Results Yet

NCT00528684 | COMPLETED | PHASE1

18 participants

Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2006-07-31

Completion:

2010-04-30

Conditions

• Malignant Glioma

Interventions

• BIOLOGICAL

No Results Yet

NCT00505687 | COMPLETED | PHASE3

186 participants

An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2005-02-28

Completion:

2008-12-31

Conditions

• Idiopathic Parkinson's Disease

Interventions

• DRUG

Results Available

NCT00503295 | COMPLETED | PHASE2

53 participants

Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2007-06-30

Completion:

2011-02-28

Conditions

• Osteosarcoma
• Ewing Sarcoma Family Tumors
• Malignant Fibrous Histiocytoma
• Sarcoma, Synovial
• Fibrosarcoma
• Leiomyosarcoma

Interventions

• BIOLOGICAL

No Results Yet

NCT00501969 | COMPLETED | PHASE3

395 participants

An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2004-08-31

Completion:

2008-12-31

Conditions

• Advanced Stage Parkinson's Disease

Interventions

• DRUG

Results Available

NCT00498186 | COMPLETED | PHASE2

295 participants

Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS)

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2003-07-31

Completion:

2009-04-30

Conditions

• Restless Legs Syndrome

Interventions

• DRUG

Results Available

NCT00447590 | COMPLETED | NA

153 participants

Effectiveness and Safety Study of LAP-BAND Treatment for Obese Adolescents

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2007-03-31

Completion:

2009-01-31

Conditions

• Morbid Obesity

Interventions

• DEVICE

Results Available

NCT00389831 | COMPLETED | PHASE2

44 participants

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2006-08-31

Completion:

2006-11-30

Conditions

• Restless Legs Syndrome

Interventions

• DRUG
• OTHER

Results Available

NCT00296192 | COMPLETED | PHASE2

82 participants

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson Symptoms

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2006-02-28

Completion:

2006-06-30

Conditions

• Parkinson's Disease

Interventions

• DRUG
• OTHER

Results Available

NCT00278447 | COMPLETED | PHASE3

569 participants

Addiction Health Evaluation And Disease Management (AHEAD) Study

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2006-04-30

Completion:

2010-01-31

Conditions

• Alcohol Dependence
• Alcoholism
• Drug Dependence

Interventions

• BEHAVIORAL

No Results Yet

NCT00249847 | TERMINATED | NA

5 participants

Study of PET Scans and Serotonin in Hot Flashes Treatment

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2005-10-31

Completion:

2007-07-31

Conditions

• Hot Flashes

Interventions

• DRUG

No Results Yet

NCT00245063 | COMPLETED | PHASE2

25 participants

AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-02

Start Date:

2006-03-31

Completion:

2010-03-31

Conditions

• Recurrent Non-small Cell Lung Cancer

Interventions

• DRUG
• OTHER

Results Available

NCT02254226 | COMPLETED | PHASE1

26 participants

Pharmacokinetics of Salmeterol (Serevent®) After Inhalation With Metered Dose Inhaler (MDI) and Diskus® in Healthy Male Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2004-11-30

Completion:

2005-01-31

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02254213 | COMPLETED

15 participants

Intra-individual Stability in Electroencephalography (EEG) Parameters

Study Type:

OBSERVATIONAL

Last Updated:

2014-10-01

Start Date:

2005-06-30

Completion:

2005-08-31

Conditions

• Stability of EEG Features in Humans

Interventions

• OTHER

No Results Yet

NCT02254187 | COMPLETED | PHASE1

30 participants

Pharmacokinetics of Salmeterol Via HandiHaler® in Healthy Male Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2005-09-30

Completion:

2005-10-31

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02254174 | COMPLETED | PHASE1

36 participants

Relative Bioavailability of Tiotropium and Salmeterol After Inhalation of a Fixed Combined Dose Compared to Monocomponents in Healthy Male Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2006-03-31

Completion:

2006-07-31

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02254135 | COMPLETED | PHASE1

24 participants

Study to Assess Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BEA 2180 BR in Healthy Male Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2006-12-31

Completion:

2007-01-31

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02254122 | COMPLETED | PHASE1

59 participants

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BEA 2180 BR in Healthy Male Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2004-05-31

Completion:

2005-02-28

Conditions

• Healthy

Interventions

• DRUG
• DEVICE

No Results Yet

NCT02254109 | COMPLETED | PHASE1

36 participants

Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Rising of BEA 2180 BR in Japanese Healthy Male Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2008-04-30

Completion:

2008-10-31

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02254096 | COMPLETED | PHASE1

46 participants

Safety, Pharmacokinetics and Pharmacodynamics of BIRT 1696 BS in Healthy Human Subjects

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2002-05-31

Completion:

2002-07-31

Conditions

• Healthy

Interventions

• DRUG
• OTHER

No Results Yet

NCT02254083 | COMPLETED | PHASE1

16 participants

Tolerability and Pharmacokinetics/-Dynamics of BIBT 986 BS in Healthy Male Subjects

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2003-02-28

Completion:

2003-05-31

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02254070 | COMPLETED | PHASE1

23 participants

Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BIBT 986 BS in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2003-06-30

Completion:

2004-08-31

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02254057 | COMPLETED | PHASE1

47 participants

Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2002-07-31

Completion:

2002-10-31

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02254044 | TERMINATED | PHASE1

7 participants

Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2003-10-31

Completion:

2004-11-30

Conditions

• Carcinoma, Squamous Cell

Interventions

• DRUG

No Results Yet

NCT02253979 | COMPLETED | PHASE4

71 participants

Comparison of VivaSightTM Double Lumen Tube With a Conventional Double Lumen Tube

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2013-01-31

Completion:

2014-07-31

Conditions

• Endotracheal Intubation
• Airway Management
• One Lung Ventilation

Interventions

• DEVICE

No Results Yet

NCT02253953 | COMPLETED | PHASE1

62 participants

Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2002-11-30

Completion:

2003-12-31

Conditions

• Healthy

Interventions

• DRUG
• OTHER

No Results Yet

NCT02253940 | COMPLETED | PHASE1

40 participants

Pharmacokinetics and Safety of BILR 355 in Healthy Male Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2006-10-31

Completion:

2006-12-31

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02253927 | COMPLETED | PHASE1

48 participants

Dose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2006-05-31

Completion:

2006-08-31

Conditions

• Healthy

Interventions

• DRUG
• OTHER

No Results Yet

NCT02253914 | COMPLETED | PHASE1

100 participants

Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2004-02-29

Completion:

2004-12-31

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02253901 | COMPLETED | PHASE1

33 participants

Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir in Healthy Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2005-03-31

Completion:

2005-05-31

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02253888 | COMPLETED | PHASE1

30 participants

Bioequivalence Study of Tipranavir Stored at Controlled Temperature Compared With Tipranavir Stored at Controlled Refrigerated Conditions, Orally Co-administered With Ritonavir in Healthy Male and Female Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2005-05-31

Completion:

2005-06-30

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02253875 | COMPLETED | PHASE1

15 participants

Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2005-11-30

Completion:

2006-02-28

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02253862 | COMPLETED | PHASE1

17 participants

Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2005-12-31

Completion:

2006-03-31

Conditions

• Healthy

Interventions

• DRUG

No Results Yet

NCT02253849 | COMPLETED | PHASE1

28 participants

Effects of TPV/r on the Pharmacokinetics of Carbamazepine in Healthy Adult Volunteers

Study Type:

INTERVENTIONAL

Last Updated:

2014-10-01

Start Date:

2005-11-30

Completion:

2006-06-30

Conditions

• Healthy

Interventions

• DRUG

No Results Yet